Cellebrite DI Ltd.
CLBT
$11.43
-$0.02-0.18%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 20.48% | 22.04% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 20.48% | 22.04% | |
| Cost of Revenue | -- | -- | 19.07% | 23.57% | |
| Gross Profit | -- | -- | 20.75% | 21.76% | |
| SG&A Expenses | -- | -- | 20.11% | 18.28% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 20.05% | 19.31% | |
| Operating Income | -- | -- | 23.16% | 41.47% | |
| Income Before Tax | -- | -- | -49.24% | -76.30% | |
| Income Tax Expenses | -- | -- | -0.97% | 23.05% | |
| Earnings from Continuing Operations | -- | -- | -46.08% | -73.63% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -46.08% | -73.63% | |
| EBIT | -- | -- | 23.16% | 41.47% | |
| EBITDA | -- | -- | 19.77% | 33.99% | |
| EPS Basic | -- | -- | -44.24% | -66.02% | |
| Normalized Basic EPS | -- | -- | 198.62% | 88.97% | |
| EPS Diluted | -- | -- | -42.79% | -62.63% | |
| Normalized Diluted EPS | -- | -- | 194.12% | 86.88% | |
| Average Basic Shares Outstanding | -- | -- | 17.62% | 13.90% | |
| Average Diluted Shares Outstanding | -- | -- | 20.10% | 15.38% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |